Depression in children and adolescents with cystic fibrosis: case studies

Larissa Elgudin1, Sunil Kishan, Don Howe

  • 1University Hospitals of Cleveland, Ohio, USA. laraelg@hotmail.com

Insights

Antidepressant medications may improve psychological outcomes for children and adolescents with cystic fibrosis (CF). Further clinical studies are needed to confirm the efficacy and safety of these treatments in CF patients.

Area of Science:

  • Medical Research
  • Pediatric Health
  • Psychiatry

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple systems, notably airways.
  • While CF treatments have improved life expectancy, psychological support remains limited.
  • CF significantly impacts patients' and families' quality of life.

Observation:

  • This study presents three pediatric cases of cystic fibrosis (CF) patients diagnosed with depression.
  • Treatment involved a combination of antidepressant medications and psychosocial interventions.
  • Two out of three patients showed positive psychological outcomes.

Findings:

  • Antidepressant medication, alongside psychosocial interventions, appears beneficial for depression in pediatric CF.
  • The findings suggest a positive influence of antidepressants on psychological well-being in this population.

Implications:

  • Further clinical trials are warranted to establish the efficacy and safety of antidepressants in CF.
  • This research highlights the need for integrated mental health care in cystic fibrosis management.
  • Future studies should assess long-term effects and optimal dosing for CF patients.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...